Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
More weight-loss medications are on the way
The study looked at whether glucagon-like peptide-1 receptor agonists (GLP-1 drugs) could have benefits beyond blood sugar control
Eli Lilly stated "Lilly is deeply concerned that products fraudulently claimed by compounding pharmacies or counterfeiters to be FDA-approved tirzepatide, Mounjaro, or Zepbound may expose patients to serious health risks." Novo Nordisk said its lawsuits "aim to protect US patients and consumers from deceptive marketing by these entities as well as potentially harmful and improperly compounded drugs claiming to contain semaglutide." At least seven deaths linked to compounded versions of semaglutide, the active ingredient in these medications, have been reported to the FDA
That isnt inherently a problem, as many chronic conditions require ongoing treatment, but it does complicate things
